Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership551,522 shares
Latest Disclosed Value $ 246,341,499
Neuberger Berman Group LLC reports 1.03% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 551,522 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $246,276,634 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 545,897 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 1.03% during the quarter. The current value of the position is $246,436,575 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 551,522 5,625 1.03 246,341 -0.46 0.1875
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 545,897 18,406 3.49 247,488 19.80 0.1842
2025-11-12 2025-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 527,491 68,341 14.88 206,587 1.06 0.1510
2025-08-25 2025-06-30 13F/A-1 VERTEX PHARMACEUTICALS Common 92532F100 459,150 16,522 3.73 204,414 -4.74 0.1573
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 459,150 16,522 204,414 0.0814
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 442,628 8,317 1.91 214,595 22.70 0.1797
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 434,311 5,173 1.21 174,896 -12.37 0.1388
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 429,138 1,650 0.39 199,583 -0.39 0.1557
2024-11-14 2024-06-30 13F/A-1 VERTEX PHARMACEUTICALS Common 92532F100 427,488 13,438 3.25 200,372 15.77 0.1645
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 427,488 13,438 200,372 0.1644
2024-11-14 2024-03-31 13F/A-1 VERTEX PHARMACEUTICALS Common 92532F100 414,050 18,270 4.62 173,077 7.48 0.1431
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 414,050 18,270 173,077 0.1430
2024-11-14 2023-12-31 13F/A-2 VERTEX PHARMACEUTICALS Common 92532F100 395,780 57,855 17.12 161,039 37.04 0.1404
2024-02-09 2023-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 395,780 57,855 161,039 0.1404
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 337,925 26,290 8.44 117,510 7.15 0.1071
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 311,635 8,617 2.84 109,667 14.87 0.0981
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 303,018 1,917 0.64 95,472 9.80 0.0885
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 301,101 35,292 13.28 86,952 12.97 0.0852
2022-11-15 2022-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 265,809 -134,151 -33.54 76,965 -31.71 0.0804
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 399,960 157,191 64.75 112,705 77.89 0.1133
2022-05-23 2022-03-31 13F/A-1 VERTEX PHARMACEUTICALS Common 92532F100 242,769 -42 -0.02 63,356 20.98 0.0537
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 242,769 -42 62,099 0.0277
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 242,811 -43,385 -15.16 52,371 1.50 0.0411
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 286,196 -123,143 -30.08 51,599 -37.30 0.0451
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 409,339 20,324 5.22 82,295 -1.25 0.0718
2021-05-13 2021-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 389,015 -3,587 -0.91 83,337 -10.10 0.0796
2021-02-10 2020-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 392,602 -45,197 -10.32 92,695 -22.13 0.0961
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 437,799 14,507 3.43 119,042 -3.09 0.1412
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 423,292 38,240 9.93 122,832 34.06 0.1527
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 385,052 5,352 1.41 91,623 10.21 0.1397
2020-02-12 2019-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 379,700 6,350 1.70 83,135 31.43 0.0970
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 373,350 13,157 3.65 63,253 -4.24 0.0773
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 360,193 11,863 3.41 66,052 3.09 0.0790
2019-05-13 2019-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 348,330 92,287 36.04 64,075 51.02 0.0785
2019-02-12 2018-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 256,043 6,951 2.79 42,429 -11.62 0.0591
2018-11-16 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS Common 92532F100 249,092 657 0.26 48,010 13.70 0.0544
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS Common 92532F100 249,092 657 48,010
2018-08-13 2018-06-30 13F VERTEX PHARMACEUTICALS Common 92532F100 248,435 3,696 1.51 42,224 5.86 0.0466
2018-05-08 2018-03-31 13F VERTEX PHARMACEUTICALS Common 92532F100 244,739 19,985 8.89 39,888 18.43 0.0456
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS Common 92532F100 224,754 1,277 0.57 33,682 -0.87 0.0387
2017-11-15 2017-09-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 223,477 -17,510 -7.27 33,977 9.41 0.0425
2017-08-08 2017-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 240,987 -5,344 -2.17 31,056 15.30 0.0399
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 246,331 12,060 5.15 26,936 56.07 0.0348
2017-02-06 2016-12-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 234,271 -343,963 -59.49 17,259 -65.77 0.0232
2016-11-02 2016-09-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 578,234 -56,654 -8.92 50,428 -7.66 0.0684
2016-08-05 2016-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 634,888 95,740 17.76 54,613 27.43 0.0752
2016-05-06 2016-03-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 539,148 -1,453 -0.27 42,857 -37.00 0.0589
2016-01-28 2015-12-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 540,601 28,747 5.62 68,024 27.62 0.0891
2015-11-10 2015-09-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 511,854 34,159 7.15 53,304 -9.63 0.0687
2015-07-31 2015-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 477,695 50,367 11.79 58,986 17.01 0.0656
2015-05-06 2015-03-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 427,328 427,328 0.00 50,412 0.0538
2015-02-05 2014-12-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 0 -48,851 -100.00 0 -100.00
2014-11-04 2014-09-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 48,851 -2,375 -4.64 5,486 13.11 0.0056
2014-08-05 2014-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 51,226 -1,725 -3.26 4,850 29.54 0.0047
2014-05-05 2014-03-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 52,951 -3,822 -6.73 3,744 -11.24 0.0038
2014-02-11 2013-12-31 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 56,773 -1,060,728 -94.92 4,218 -95.02 0.0043
2013-10-29 2013-09-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 1,117,501 -984,883 -46.85 84,729 -49.66 0.0941
2013-08-13 2013-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 2,102,384 2,102,384 168,317 0.2001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.